Sections
Title | Starting Page | Number of Pages |
---|
1 Table of Contents | 2 | 2 |
1.1 List of Tables | 3 | 1 |
1.2 List of Figures | 3 | 1 |
2 Introduction | 3 | 3 |
2.1 What Is This Report About? | 4 | 1 |
2.2 Medical Imaging Information Systems Market Segmentation | 4 | 1 |
2.3 Definitions of Markets Covered in the Report | 5 | 1 |
3 Medical Imaging Information Systems Market, South Korea | 6 | 11 |
3.1 Medical Imaging Information Systems Market, South Korea, Revenue ($m), 2008-2015 | 6 | 2 |
3.2 Medical Imaging Information Systems Market, South Korea, Revenue ($m), 2015-2022 | 8 | 2 |
3.2.1 Picture Archiving and Communication System (PACS) Market, South Korea, Revenue ($m), by Segment, 2008-2015 | 10 | 2 |
3.2.2 Picture Archiving and Communication System (PACS) Market, South Korea, Revenue ($m), by Segment, 2015-2022 | 12 | 2 |
3.3 Medical Imaging Information Systems Market, South Korea, Distribution Share by Revenue ($m), 2014-2015 | 14 | 1 |
3.4 Medical Imaging Information Systems Market, South Korea, Company Share by Revenue ($m), 2015 | 15 | 2 |
4 Overview of Key Companies in South Korea, Medical Imaging Information Systems Market | 17 | 2 |
4.1 Fujifilm Holdings Corporation | 17 | 1 |
4.1.1 Company Overview | 17 | 1 |
4.2 GE Healthcare Limited | 17 | 1 |
4.2.1 Company Overview | 17 | 1 |
4.3 Carestream Health, Inc. | 17 | 1 |
4.3.1 Company Overview | 17 | 1 |
4.4 Philips Healthcare | 17 | 1 |
4.4.1 Company Overview | 17 | 1 |
4.5 Siemens Healthcare GmbH | 18 | 1 |
4.5.1 Company Overview | 18 | 1 |
4.6 Fujitsu Limited | 18 | 1 |
4.6.1 Company Overview | 18 | 1 |
4.7 Elekta AB | 18 | 1 |
4.7.1 Company Overview | 18 | 1 |
5 Medical Imaging Information Systems Market Pipeline Products | 19 | 1 |
6 Appendix | 20 | 5 |
6.1 Research Methodology | 21 | 3 |
6.1.1 Coverage | 21 | 1 |
6.1.2 Secondary Research | 21 | 1 |
6.1.3 Primary Research | 22 | 1 |
6.1.4 Company Share Analysis | 22 | 1 |
6.1.5 Distribution Share Analysis | 22 | 1 |
6.1.6 Benchmarking | 23 | 1 |
6.2 GlobalData Consulting | 23 | 1 |
6.3 Contact Us | 23 | 1 |
6.4 Disclaimer | 24 | 1 |